News – Page 867 – Endpoints News

Targeting the BFPs of the CNS, Biogen licenses map of genetic neighborhoods in the brain

6 years ago

Merck-partnered biotech hands Roche its half-life extension tech as it pivots to immuno-oncology

6 years ago

Blackstone plots $4.5B+ life sciences fund — and they've already secured the bulk of it

6 years ago

Eli Lilly buys a Roche discard in $1.1B Dermira buyout. Can they go toe-to-toe with the heavyweight challenger ...

6 years ago

STUNG: Aduro CEO Stephen Isaacs reaches for the budget ax — again — on the heels of their latest setback with ...

6 years ago

Blueprint scores first FDA OK for a precision GIST cancer drug, just ahead of a rival treatment. And the price is a ...

6 years ago

Moderna CEO Bancel offers a thumbs-up on latest update for their CMV program — with blockbuster hopes for what's ...

6 years ago

Credibility shredded, AMAG jettisons CEO and 2 drugs as it looks to reorganize around a salvage plan

6 years ago

Schrödinger adds another Big Pharma partner; Grey Wolf bags $3.3M to 'illuminate' tumors

6 years ago

Second pivotal study bodes well for VBI's hep B vaccine

6 years ago

DCVC Bio, 5AM back colonizing army of genetically engineered gut bacteria with $33M

6 years ago

Ionis finds new partner in a young biotech and its hopeful founder

6 years ago

Controversial Duchenne MD player Solid Bio takes another hit, laying off staffers in a bid to weather FDA hold

6 years ago

Eyeing the 'translatome,' Pfizer ties another knot with biotech partner for preclinical, next-gen targeted therapies

6 years ago

Regeneron’s pivotal trial for an ultra-rare disease fails the primary — but don't count them out at the FDA

6 years ago

Sanofi antes up $55M to add protein degradation tech to the R&D playbook as execs look to revive the pipeline

6 years ago

Merck's Keytruda wins another first — this time for an FDA nod to treat a subset of bladder cancer patients

6 years ago

ADC Therapeutics clears a big hurdle toward its first BLA as pivotal PhII delivers upbeat ORR results

6 years ago

Boehringer Ingelheim inks 'Singapore's largest biotech deal,' promising $1B each for a suite of anti-fibrotic IL-11 ...

6 years ago

Primed for attack: Vaccine tech maker gets $11M shot to battle infectious disease

6 years ago

Shreds of Tregs: French biotech wins Medicxi backing to kill the rogue immunosuppressive agent to fight cancer

6 years ago

Scoop: Sanofi quietly ties up with a low-profile, preclinical cancer biotech — FTC signs off

6 years ago

Stanley and Rosanne Crooke stay focused on anti-sense, stealing back patients from disease with N-of-1 tech

6 years ago

Xencor, Verastem ink new deals; Scynexis' lead drug scores again

6 years ago

First page Previous page 864 865 866867868 869 870 Next page Last page